472 related articles for article (PubMed ID: 11410498)
21. Receptor-regulated and inhibitory Smads are critical in regulating transforming growth factor beta-mediated Meckel's cartilage development.
Ito Y; Bringas P; Mogharei A; Zhao J; Deng C; Chai Y
Dev Dyn; 2002 May; 224(1):69-78. PubMed ID: 11984875
[TBL] [Abstract][Full Text] [Related]
22. A novel SMAD4 gene mutation in seminoma germ cell tumors.
Bouras M; Tabone E; Bertholon J; Sommer P; Bouvier R; Droz JP; Benahmed M
Cancer Res; 2000 Feb; 60(4):922-8. PubMed ID: 10706106
[TBL] [Abstract][Full Text] [Related]
23. Lack of activated Smad2 in transforming growth factor-beta signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma.
Fukuchi M; Nakajima M; Miyazaki T; Masuda N; Osawa H; Manda R; Tsukada K; Kato H; Kuwano H
J Surg Oncol; 2006 Jul; 94(1):51-6. PubMed ID: 16788944
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-beta, Smads, and cancer.
Grady WM
Clin Cancer Res; 2005 May; 11(9):3151-4. PubMed ID: 15867206
[No Abstract] [Full Text] [Related]
25. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.
Goumans MJ; Valdimarsdottir G; Itoh S; Rosendahl A; Sideras P; ten Dijke P
EMBO J; 2002 Apr; 21(7):1743-53. PubMed ID: 11927558
[TBL] [Abstract][Full Text] [Related]
26. TGF-beta receptor expression and smad2 localization are cell density dependent in fibroblasts.
Petridou S; Maltseva O; Spanakis S; Masur SK
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):89-95. PubMed ID: 10634606
[TBL] [Abstract][Full Text] [Related]
27. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
28. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
29. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
Mori Y; Chen SJ; Varga J
Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
[TBL] [Abstract][Full Text] [Related]
30. Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus.
Natsugoe S; Xiangming C; Matsumoto M; Okumura H; Nakashima S; Sakita H; Ishigami S; Baba M; Takao S; Aikou T
Clin Cancer Res; 2002 Jun; 8(6):1838-42. PubMed ID: 12060625
[TBL] [Abstract][Full Text] [Related]
31. Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.
Park YN; Chae KJ; Oh BK; Choi J; Choi KS; Park C
Hepatogastroenterology; 2004; 51(56):396-400. PubMed ID: 15086168
[TBL] [Abstract][Full Text] [Related]
32. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
Alvarez J; Serra R
Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
[TBL] [Abstract][Full Text] [Related]
33. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
[TBL] [Abstract][Full Text] [Related]
34. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
Suh N; Roberts AB; Birkey Reffey S; Miyazono K; Itoh S; ten Dijke P; Heiss EH; Place AE; Risingsong R; Williams CR; Honda T; Gribble GW; Sporn MB
Cancer Res; 2003 Mar; 63(6):1371-6. PubMed ID: 12649201
[TBL] [Abstract][Full Text] [Related]
35. Smad signal and TGFbeta induced apoptosis in human lymphoma cells.
Sebestyén A; Barna G; Nagy K; Jánosi J; Paku S; Kohut E; Berczi L; Mihalik R; Kopper L
Cytokine; 2005 Jun; 30(5):228-35. PubMed ID: 15927846
[TBL] [Abstract][Full Text] [Related]
36. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification.
Sakou T; Onishi T; Yamamoto T; Nagamine T; Sampath Tk; Ten Dijke P
J Bone Miner Res; 1999 Jul; 14(7):1145-52. PubMed ID: 10404014
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-beta induced collagenase-3 production in human osteoarthritic chondrocytes is triggered by Smad proteins: cooperation between activator protein-1 and PEA-3 binding sites.
Tardif G; Reboul P; Dupuis M; Geng C; Duval N; Pelletier JP; Martel-Pelletier J
J Rheumatol; 2001 Jul; 28(7):1631-9. PubMed ID: 11469472
[TBL] [Abstract][Full Text] [Related]
38. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
39. Smad6 inhibits signalling by the TGF-beta superfamily.
Imamura T; Takase M; Nishihara A; Oeda E; Hanai J; Kawabata M; Miyazono K
Nature; 1997 Oct; 389(6651):622-6. PubMed ID: 9335505
[TBL] [Abstract][Full Text] [Related]
40. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines.
Kashiwagi Y; Horie K; Kanno C; Inomata M; Imamura T; Kato M; Yamamoto T; Yamashita H
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):679-85. PubMed ID: 19737884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]